Financial Performance - Consolidated net sales for the three months ended December 31, 2024, were 186,176,000,anincreaseof14,314,000, or 8.3%, from 171,862,000inthesameperiodof2023[112]−GrossprofitforthethreemonthsendedDecember31,2024,was44,882,000, representing a gross margin of 24.1%, compared to 30,043,000and17.517,581,000, an increase from 9,524,000inthesameperiodof2023[120]−ConsolidatednetsalesfortheninemonthsendedDecember31,2024,were564,249,000, an increase of 36,043,000,or6.8528,206,000 in the same period of 2023[126] - Gross profit for the nine months ended December 31, 2024, was 115,333,000,withagrossmarginof20.497,758,000 and 18.5% in the same period of 2023[128] Expenses and Costs - Interest expense for the three months ended December 31, 2024, decreased by 3,862,000,or21.114,435,000 from 18,297,000inthesameperiodof2023[121]−CashflowprovidedbyoperationsforthethreemonthsendedDecember31,2024,was34,357,000, down from 53,615,000inthesameperiodof2023[111]−CashflowprovidedbyoperationsfortheninemonthsendedDecember31,2024,was36,368,000, compared to 48,445,000inthesameperiodof2023[125]−ResearchanddevelopmentexpensesforthethreemonthsendedDecember31,2024,increasedby469,000, or 18.5%, to 3,008,000from2,539,000 in the same period of 2023[118] - General and administrative expenses increased by 5,809,000,or13.847,934,000 for the nine months ended December 31, 2024, primarily due to foreign currency losses and increased severance costs[130] - Research and development expenses rose by 532,000,or7.27,884,000 for the nine months ended December 31, 2024, driven by increased headcount[132] Financial Position and Cash Flow - Consolidated operating income decreased to 23,645,000fortheninemonthsendedDecember31,2024,downfrom33,902,000 in the prior year, largely due to a non-cash loss of 18,966,000fromforeignexchangeimpacts[134]−Interestexpensedecreasedby2,396,000, or 5.3%, to 43,004,000fortheninemonthsendedDecember31,2024,attributedtoloweraverageoutstandingbalancesandinterestrates[135]−Netcashprovidedbyoperatingactivitieswas36,368,000 for the nine months ended December 31, 2024, down from 48,445,000inthepreviousyear,influencedbychangesinaccountspayableandreceivable[144]FinancingandCapitalExpenditures−Thecompanyhad268,620,000 in senior secured financing, including a 238,620,000revolvingloanfacilityanda30,000,000 term loan facility, with the credit facility maturing on December 12, 2028[147] - As of December 31, 2024, 94,802,000wasoutstandingundertherevolvingfacility,withaninterestrateof7.662,531,000 for the nine months ended December 31, 2024, compared to 559,000in2023,markinganincreaseofapproximately3525,000,000 in capital expenditures during fiscal 2025 to support global growth initiatives and current operations[158] Supplier Finance and Obligations - Commitments from participating financial institutions in the supplier finance program increased to 27,000,000from15,000,000 during the three months ended December 31, 2024[157] - Outstanding supplier obligations confirmed as valid under the supplier finance program amounted to 31,809,000asofDecember31,2024[157]OtherFinancialInformation−Thechangeinfairvalueofthecompoundnetderivativeliabilityassociatedwithconvertiblenotesresultedinanon−cashgainof2,460,000 for the nine months ended December 31, 2024[136] - The company repurchased 268,130 shares of common stock for 2,096,000duringtheninemonthsendedDecember31,2024,with20,841,000 utilized and 16,159,000remainingunderthesharerepurchaseprogram[143]−Accountsreceivablediscountedincreasedto488,505,000 for the nine months ended December 31, 2024, compared to 465,073,000in2023,reflectingagrowthofapproximately5.581,000 and $243,000 for the three and nine months ended December 31, 2024, respectively[159] - The company has no material changes in market risk from the previous disclosures as of March 31, 2024[170] - The company is currently evaluating the impact of new accounting standards issued by the FASB on its financial statement disclosures[164][167][169] - There is an immaterial amount accrued related to various lawsuits and claims against the company[162]